Sapphiros Awarded $11M from NIH RADx® Tech to Develop a Next-generation Molecular OTC Test

BOSTON, Apr. 17, 2023 /PRNewswire/ — Sapphiros, a platform company dedicated to building the next generation of consumer diagnostic technologies, is proud to announce it has been selected by the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech program to develop a high performance, over-the-counter (OTC), molecular multiplex respiratory diagnostic test that can […]

Sapphiros Taps Teresa Abraham for VP of Scientific and Technical Affairs

BOSTON, Jan. 25, 2023 /PRNewswire/ — Sapphiros, a platform dedicated to building the next generation of consumer diagnostics, backed by KKR, is pleased to announce the appointment of Teresa Abraham, PhD, as its new Vice President of Scientific and Technical Affairs. Dr. Abraham will be responsible for partnerships that accelerate technology development and clinical research […]

Biocrucible, a Sapphiros Company, Appoints Per Grufman as CEO

CAMBRIDGE, U.K., Jan. 20, 2023 /PRNewswire/ — Biocrucible, a Sapphiros platform company dedicated to building the next generation of consumer diagnostics, announced the appointment of Per Grufman, Ph.D., as its Chief Executive Officer. A biotech industry veteran of thirty years, Dr. Grufman will lead the development and commercialization of Biocrucible’s isothermal amplification technologies for next-generation […]

Sapphiros Appoints Mark Gladwell as CEO and President

BOSTON, Oct. 27, 2022 /PRNewswire/ — Sapphiros, a platform dedicated to building the next generation of consumer diagnostic technologies, today announced the promotion of Mark Gladwell, Sapphiros’s Chief Operating Officer (“COO”) to President and Chief Executive Officer (“CEO”). Namal Nawana, founder of Sapphiros, will continue to remain closely involved as Executive Chairman. Namal Nawana, Sapphiros […]

Sapphiros Acquires Flexotronix Limited

BOSTON — Sapphiros has today completed the acquisition of Flexotronix Limited. Flexotronix have developed a high speed printed electronics manufacturing line using in-house proprietary conductive inks and printed components, including batteries connectivity capability – and other diagnostic test control mechanisms. These technologies will be rapidly deployed across the Sapphiros portfolio of companies to dramatically lower […]

Mike Musgnug Joins Sapphiros as Executive Vice President, Strategy and CEO, GrapheneDx

Boston, MA, September 6th, Sapphiros announced today that Mike Musgnug has joined the company as EVP Strategy for Sapphiros and CEO of GrapheneDX, a Sapphiros Group Company. In this role, Mike will lead strategy development and business development for Sapphiros in addition to leading the GrapheneDX organization. Prior to joining Sapphiros, Mr. Musgnug served as […]

Satio and Institut Pasteur de Dakar Form Strategic Partnership on Research, Development, Manufacture, and Distribution of Next Generation Healthcare Technologies

The partnership aims to enable low-cost access to vaccines and diagnostics to advance public health in Africa and beyond. BOSTON–(BUSINESS WIRE)–Satio, Inc., a privately held medical device company developing breakthrough, consumer-driven diagnostic and drug delivery solutions, today announced a strategic partnership agreement with Institut Pasteur de Dakar. By combining SatioRxTM intradermal patches and Institut Pasteur de Dakar […]

Satio and INTACT Form Strategic Partnership to Jointly Improve Delivery of Mass Vaccination

BOSTON–(BUSINESS WIRE)–Satio and INTACT Solutions have entered into an agreement to establish a collaborative framework in order to partner on research, development, manufacture, and deployment of next generation health technologies with the goal of offering alternative solutions to traditional needles with SatioRx™ intradermal patches for the Member States of the African Union and beyond. The joint force aims […]

Sapphiros, a Next-Generation Diagnostics Platform, Announces Executive Appointments

MENLO PARK, Calif.–(BUSINESS WIRE)–Sapphiros, a KKR-backed platform building the next generation of diagnostic technologies, today announced the appointment of Mark Gladwell as Chief Operating Officer and Dr. Niall Armes as Chief Technology Officer. Mr. Gladwell and Dr. Armes will work alongside Sapphiros Executive Chairman Namal Nawana to provide strategic and operational support to the platform’s […]

Gates Foundation backs Biocrucible’s COVID-19 venture

Biocrucible Ltd at Granta Park in the Cambridge technology cluster has received funding from the Bill & Melinda Gates Foundation to explore rapid molecular testing options for COVID-19 and other pathogens, which could be used in the home or in field settings. Cambridge-based office design and fit-out business COEL and a fellow city company, lab […]